Table 6.
Univariate and multivariate analysis of possible factors that contributed to complete remission in the 57 patients with IgAN
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95 % CI | P value | HR | 95 % CI | P value | |
| Age (per 1 year of age) | 1.06 | (0.97–1.03) | 0.833 | 1.04 | (1.00–1.10) | 0.172 |
| Female gender (vs. male) | 0.49 | (0.21–1.12) | 0.091 | 0.44 | (0.16–0.93) | 0.029* |
| Duration from onset (months) | 0.99 | (0.97–1.00) | 0.158 | 0.99 | (0.97–1.00) | 0.157 |
| IgG deposition (vs. absence) | 0.35 | (0.14–0.82) | 0.014* | 0.31 | (0.12–0.77) | 0.016* |
| History of hypertension (vs. absence) | 0.87 | (0.38–1.99) | 0.772 | 0.57 | (0.20–1.56) | 0.278 |
| Proteinuria (per 0.5 g/day) | 0.75 | (0.53–1.01) | 0.504 | 0.67 | (0.43–1.01) | 0.048* |
| eGFR (per 10 ml/min) | 1.04 | (0.89–1.21) | 0.644 | 1.03 | (0.81–1.32) | 0.821 |
| Histological grade (per grade) | 0.92 | (0.47–1.62) | 0.798 | 1.28 | (0.64–2.34) | 0.453 |
| Use of RASI (vs. absence) | 1.04 | (0.30–6.53) | 0.938 | 0.45 | (0.09–3.42) | 0.397 |
| Underwent ST (vs. absence) | 1.77 | (0.74–4.92) | 0.212 | 3.47 | (1.17–12.26) | 0.023* |
HR hazard ratio, CI confidence interval, RASI renin-angiotensin system inhibitor, ST steroid pulse therapy combined with tonsillectomy
* P < 0.05